Xspray Microparticles AB

At XSpray we specialize in the formulation of protein kinase inhibitors, many of which suffer from formulation related medical problems.

The XSpray HyNap™ is a PLATFORM TECHNOLOGY that addresses the formulation related drawbacks of small molecule PKI’s and can improve the solubility and bioavailability of even the most challenging drug substances. Whether you’re developing a new drug or looking to improve the product profile of a currently marketed drug we can help you get to market faster with a better product.


Kategorier: Biotech, Life Science Consultants

Gå till Xspray Microparticles ABs hemsida